Search results
Results from the WOW.Com Content Network
The Environmental Campus Birkenfeld (ECB) (German: Umwelt-Campus Birkenfeld (UCB)) is a branch of the Hochschule Trier in the state of Rhineland-Palatinate, Germany. It is close to the small town of Birkenfeld in Rhineland-Palatinate, close to the border of Saarland, Luxembourg, Belgium and France. There are 1,800 students enrolled in two ...
The Ernst Ludwig Ehrlich Scholarship Fund (German: Ernst Ludwig Ehrlich Studienwerk or ELES for short) is one of thirteen Federally-funded Scholarship Foundations in the Federal Republic of Germany. It is located in Berlin. The Scholarship Fund was named after religious scholar and historian Ernst Ludwig Ehrlich (1921-2007).
Apixaban is a highly selective, orally bioavailable, and reversible direct inhibitor of free and clot-bound factor Xa. Factor Xa catalyzes the conversion of prothrombin to thrombin, the final enzyme in the coagulation cascade that is responsible for fibrin clot formation. [ 28 ]
The DAAD itself does not offer programs of study or courses, but awards competitive, merit-based grants for use toward study and/or research in Germany at any of the accredited German institutions of higher education. It also awards grants to German students, doctoral students, and scholars for studies and research abroad.
New Eliquis® (apixaban) Post-hoc Subanalysis of the Phase III ARISTOTLE trial Demonstrated that within 30 Days of a Procedure, Stroke or Systemic Embolism and Major Bleeding were Uncommon Results ...
Alternatives to BAföG include the Bildungskredit ("study loan") from KfW, Bildungsfonds, and scholarships. However, in most cases to qualify for a private loan, one must have German citizenship, have EU citizenship and have resided in Germany for three consecutive years, or have graduated from a German secondary school.
Alumniportal Deutschland is a non-profit online social network of "Germany Alumni" that is designed internationally for people who have studied, researched, worked or completed further training or a language course in Germany or at a German institution abroad.
The second one was apixaban (Eliquis), approved in Europe in 2011 [2] and in the United States in 2012. [3] The third one edoxaban (Lixiana, Savaysa) was approved in Japan in 2011 and in Europe and the US in 2015. [4] Betrixaban (Bevyxxa) was approved in the US in 2017.